Myelodysplastic Syndrome
Conditions
Interventions
Myelodysplastic Syndrome:Qinghuang powder combined with tonifying kidney and strengthening spleen prescription
Sponsors
Beijing Chinese Medicine Hospital affiliated to Capital Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who accord with MDS diagnostic criteria; 2. Patients who volunteer and sign informed consent; 3. Aged 18-75 years old; 4. Patients without serious complications in liver and kidney; 5. Patients who is not participating in other clinical studies.
Exclusion criteria
Exclusion criteria: 1. Patients with serious complications in Heart liver and kidney; 2. Patients with mental illness can not be matched with the treatment; 3. Pregnant women and Lactating women and patients with mental illness; 4. Patients who happen serious adverse reactions during the medication and be allergic to the drug; 5. Patients who is participating in other clinical studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HDAC1 gene; | — |
Secondary
| Measure | Time frame |
|---|---|
| HIF-1a mRNA;HIF-1a protein levels;EPO; | — |
Countries
China
Contacts
Public ContactGao Fei
Beijing Chinese Medicine Hospital affiliated to Capital Medical University
Outcome results
None listed